Prestige Consumer Healthcare Inc. (PBH) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Prestige Consumer Healthc... (PBH)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

75.71

1.08 (1.45%)

At close: Jan 14, 2025, 3:59 PM

75.78

0.09%

After-hours Jan 14, 2025, 04:10 PM EST

undefined% (undefined)

Bid	72.5
Market Cap	3.74B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.1
PE Ratio (ttm)	18.47
Forward PE	n/a
Analyst	Buy

Ask	76.22
Volume	137,139
Avg. Volume (20D)	277,300
Open	74.50
Previous Close	74.63
Day's Range	74.50 - 76.20
52-Week Range	58.22 - 86.36
Beta	undefined

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...

[Show more]

Industry Medical - Distribution

Sector Healthcare

IPO Date Feb 10, 2005

Employees 570

Stock Exchange NYSE

Ticker Symbol PBH

Website https://www.prestigebrands.com

Analyst Forecast

According to 3 analyst ratings, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $81, which is an increase of 6.99% from the latest price.

Buy 66.67%

Hold 33.33%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on Feb 6, 2025, before market opens.
Analysts project revenue of $287.65M, reflecting a 1.74% YoY growth and earnings per share of 1.16, making a 9.43% increase YoY.

Why Price Moved

8 months ago · Source

-7.01%

Prestige Consumer shares are trading lower after t... Unlock content with Pro Subscription

8 months ago · Source

+1.38%

Prestige Consumer shares are trading lower after the company reported worse-than-expected Q4 financial results and issued weak guidance.

News

2 weeks ago · zacks.com

PBH vs. BSX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest...

2 weeks ago · zacks.com

5 Beaten-Down MedTech Stocks Set to Rebound in 2025

Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.

2 weeks ago · zacks.com

Should Prestige Consumer Stock Stay in Your Portfolio Right Now?

Investors remain optimistic about PBH stock due to its strong focus on brand building.

1 month ago · zacks.com

PBH or ABT: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the bett...

1 month ago · seekingalpha.com

Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border

Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a ...

1 month ago · zacks.com

PBH or SYK: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?

2 months ago · zacks.com

PBH vs. SYK: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value inv...

2 months ago · seekingalpha.com

Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript

Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairm...

2 months ago · zacks.com

PBH Q2 Earnings Match Estimates, Revenues Beat, Shares Rise

Prestige Consumer Healthcare's second-quarter sales are impacted by the ongoing supply chain challenges in the Clear Eyes business.

2 months ago · zacks.com

Prestige Consumer Healthcare (PBH) Meets Q2 Earnings Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.09 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.07 per share a year ago.